{"id":12732,"date":"2025-07-22T08:24:08","date_gmt":"2025-07-22T12:24:08","guid":{"rendered":"https:\/\/www.rigicon.com\/glossary-term\/active-monitoring\/"},"modified":"2026-10-06T12:50:55","modified_gmt":"2026-10-06T16:50:55","slug":"monitoramento-ativo","status":"publish","type":"glossary-term","link":"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/monitoramento-ativo\/","title":{"rendered":"Monitoramento Ativo"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":0,"template":"","glossary-category":[126],"glossary-product":[],"class_list":["post-12732","glossary-term","type-glossary-term","status-publish","hentry","glossary-category-urological-conditions"],"acf":{"gt-definition":"<p>O monitoramento ativo, tamb\u00e9m conhecido como vigil\u00e2ncia ativa, \u00e9 uma estrat\u00e9gia de observa\u00e7\u00e3o rigorosa de uma condi\u00e7\u00e3o sem tratamento imediato, intervindo apenas se houver progress\u00e3o.<sup>1<\/sup> Essa abordagem envolve monitoramento regular por meio de exames e avalia\u00e7\u00f5es programados para acompanhar quaisquer altera\u00e7\u00f5es na condi\u00e7\u00e3o.<sup>2<\/sup> \u00c9 usado principalmente para condi\u00e7\u00f5es de crescimento lento ou que representam risco imediato m\u00ednimo, particularmente em casos em que os poss\u00edveis efeitos colaterais do tratamento podem superar os benef\u00edcios de uma interven\u00e7\u00e3o imediata.<sup>3<\/sup> O monitoramento ativo permite que os profissionais de sa\u00fade adiem ou evitem tratamentos desnecess\u00e1rios, mantendo a capacidade de intervir prontamente caso a condi\u00e7\u00e3o piore.<sup>4<\/sup> Essa abordagem \u00e9 mais comumente aplicada no manejo do c\u00e2ncer de pr\u00f3stata de baixo risco, mas tamb\u00e9m pode ser aplicada a outras condi\u00e7\u00f5es.<sup>5<\/sup><\/p>","gt-synonyms":"Vigil\u00e2ncia ativa, espera vigilante, manejo expectante, observa\u00e7\u00e3o, protocolo de vigil\u00e2ncia, protocolo de monitoramento, tratamento diferido","gt-citation":"[1] Cooperberg MR, Meeks W, Fang R, Gaylis FD, Catalona WJ, Makarov DV. Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US. JAMA Netw Open. 2023;6(3):e231439. DOI: 10.1001\/jamanetworkopen.2023.1439\n\n[2] National Cancer Institute. Definition of active surveillance. Cancer.gov. https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/active-surveillance. Accessed June 2, 2025.\n\n[3] Mayo Clinic. Active surveillance for prostate cancer. https:\/\/www.mayoclinic.org\/tests-procedures\/active-surveillance-for-prostate-cancer\/about\/pac-20384946. Updated November 15, 2023. Accessed June 2, 2025.\n\n[4] American Cancer Society. Observation or Active Surveillance for Prostate Cancer. https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/treating\/watchful-waiting.html. Updated November 22, 2023. Accessed June 2, 2025.\n\n[5] Moore CM, King LE, Withington J, et al. Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer-A Report of a Movember International Consensus Meeting. Eur Urol Oncol. 2023;6(2):160-182. DOI: 10.1016\/j.euo.2023.01.003. PMID: 36710133.","gt-clinical-context":"<p>O monitoramento ativo \u00e9 utilizado principalmente em contextos cl\u00ednicos em que a interven\u00e7\u00e3o imediata pode n\u00e3o ser necess\u00e1ria ou ben\u00e9fica.<sup>1<\/sup> Sua aplica\u00e7\u00e3o mais comum \u00e9 no manejo do c\u00e2ncer de pr\u00f3stata de baixo risco, no qual se tornou a abordagem preferencial segundo as principais diretrizes cl\u00ednicas.<sup>2<\/sup> Essa estrat\u00e9gia \u00e9 particularmente adequada para pacientes com tumores pequenos e de crescimento lento, restritos a uma \u00e1rea espec\u00edfica e que n\u00e3o causam sintomas.<sup>3<\/sup><\/p>\n\n<p>Os crit\u00e9rios de sele\u00e7\u00e3o de pacientes para o monitoramento ativo normalmente incluem:<\/p>\n<ul>\n    <li>Classifica\u00e7\u00e3o da doen\u00e7a como de baixo risco (por exemplo, escore de Gleason baixo no c\u00e2ncer de pr\u00f3stata)<sup>4<\/sup><\/li>\n    <li>Extens\u00e3o limitada da doen\u00e7a (por exemplo, restrita a uma \u00fanica \u00e1rea)<sup>3<\/sup><\/li>\n    <li>Aus\u00eancia de sintomas relacionados \u00e0 condi\u00e7\u00e3o<sup>3<\/sup><\/li>\n    <li>Considera\u00e7\u00e3o da idade do paciente e de comorbidades que possam limitar a expectativa de vida<sup>4<\/sup><\/li>\n<\/ul>\n\n<p>O protocolo de monitoramento geralmente envolve:<\/p>\n<ul>\n    <li>Consultas m\u00e9dicas regulares (normalmente a cada 3-6 meses)<sup>4<\/sup><\/li>\n    <li>Exames de sangue peri\u00f3dicos (por exemplo, dosagem de PSA no c\u00e2ncer de pr\u00f3stata)<sup>4<\/sup><\/li>\n    <li>Exames de imagem em intervalos definidos (por exemplo, resson\u00e2ncia magn\u00e9tica)<sup>5<\/sup><\/li>\n    <li>Bi\u00f3psias repetidas quando indicadas por altera\u00e7\u00f5es em outros par\u00e2metros<sup>5<\/sup><\/li>\n<\/ul>\n\n<p>Os resultados esperados com o monitoramento ativo incluem:<\/p>\n<ul>\n    <li>Evitar efeitos colaterais de tratamentos desnecess\u00e1rios para muitos pacientes<sup>4<\/sup><\/li>\n    <li>Preserva\u00e7\u00e3o da qualidade de vida durante o per\u00edodo de monitoramento<sup>4<\/sup><\/li>\n    <li>Nenhum impacto significativo na sobrevida c\u00e2ncer-espec\u00edfica para pacientes adequadamente selecionados<sup>5<\/sup><\/li>\n    <li>Possibilidade de interven\u00e7\u00e3o tardia caso se detecte progress\u00e3o<sup>5<\/sup><\/li>\n<\/ul>\n\n<p>A decis\u00e3o de passar do monitoramento ativo para o tratamento ativo normalmente se baseia em evid\u00eancias de progress\u00e3o da doen\u00e7a, como aumento dos n\u00edveis de biomarcadores, altera\u00e7\u00f5es nos achados de imagem ou piora dos sintomas.<sup>5<\/sup><\/p>","gt-related-evidence":null,"gt-featured":true,"gt-ai-referenced":false,"gt-view-count":92},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.7 (Yoast SEO v28.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Monitoramento Ativo: Acompanhamento Urol\u00f3gico | Rigicon<\/title>\n<meta name=\"description\" content=\"Saiba sobre monitoramento ativo na urologia: acompanhamento regular de condi\u00e7\u00f5es como angiomiolipoma, c\u00e1lculos renais e tumores de baixo risco. EAU.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/monitoramento-ativo\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Monitoramento Ativo - Prosthetic Urology Glossary\" \/>\n<meta property=\"og:description\" content=\"Explore Rigicon\u2019s evidence-based glossary covering penile implants, AUS, ED treatments, and surgical terms in prosthetic urology.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/monitoramento-ativo\/\" \/>\n<meta property=\"og:site_name\" content=\"Rigicon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/rigiconurology\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-06T16:50:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rigicon.com\/wp-content\/uploads\/2025\/05\/header-d.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1440\" \/>\n\t<meta property=\"og:image:height\" content=\"718\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@rigiconurology\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/glossary-term\\\/monitoramento-ativo\\\/\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/glossary-term\\\/monitoramento-ativo\\\/\",\"name\":\"Monitoramento Ativo: Acompanhamento Urol\u00f3gico | Rigicon\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#website\"},\"datePublished\":\"2025-07-22T12:24:08+00:00\",\"dateModified\":\"2026-10-06T16:50:55+00:00\",\"description\":\"Saiba sobre monitoramento ativo na urologia: acompanhamento regular de condi\u00e7\u00f5es como angiomiolipoma, c\u00e1lculos renais e tumores de baixo risco. EAU.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/glossary-term\\\/monitoramento-ativo\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/glossary-term\\\/monitoramento-ativo\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/glossary-term\\\/monitoramento-ativo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Glossary Terms\",\"item\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/urology-glossary\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Monitoramento Ativo\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#website\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/\",\"name\":\"Rigicon\",\"description\":\"Innovative Urological Solutions\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#organization\"},\"alternateName\":\"Innovative Urological Solutions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#organization\",\"name\":\"Rigicon, Inc.\",\"alternateName\":\"Innovative Urological Solutions\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-Logo-Square-Kopya.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-Logo-Square-Kopya.jpg\",\"width\":512,\"height\":512,\"caption\":\"Rigicon, Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/rigiconurology\\\/\",\"https:\\\/\\\/x.com\\\/rigiconurology\",\"https:\\\/\\\/www.instagram.com\\\/rigiconurology\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@Rigicon\\\/podcasts\",\"https:\\\/\\\/www.youtube.com\\\/Rigicon\",\"https:\\\/\\\/www.threads.com\\\/@rigiconurology\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/rigicon\\\/\",\"https:\\\/\\\/www.wikidata.org\\\/wiki\\\/Q141595822\"],\"description\":\"A Rigicon \u00e9 uma fabricante especializada, sediada nos EUA, de dispositivos de urologia prot\u00e9tica: pr\u00f3teses penianas, esf\u00edncteres urin\u00e1rios artificiais e pr\u00f3teses testiculares, comercializados em mais de 75 pa\u00edses.\",\"email\":\"operations@rigicon.com\",\"telephone\":\"+1 (888) 202-9790\",\"legalName\":\"Rigicon, Inc.\",\"vatID\":\"81-3545645\",\"taxID\":\"81-3545645\",\"duns\":\"045247683\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Monitoramento Ativo: Acompanhamento Urol\u00f3gico | Rigicon","description":"Saiba sobre monitoramento ativo na urologia: acompanhamento regular de condi\u00e7\u00f5es como angiomiolipoma, c\u00e1lculos renais e tumores de baixo risco. EAU.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/monitoramento-ativo\/","og_locale":"pt_BR","og_type":"article","og_title":"Monitoramento Ativo - Prosthetic Urology Glossary","og_description":"Explore Rigicon\u2019s evidence-based glossary covering penile implants, AUS, ED treatments, and surgical terms in prosthetic urology.","og_url":"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/monitoramento-ativo\/","og_site_name":"Rigicon","article_publisher":"https:\/\/www.facebook.com\/rigiconurology\/","article_modified_time":"2026-10-06T16:50:55+00:00","og_image":[{"width":1440,"height":718,"url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2025\/05\/header-d.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@rigiconurology","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/monitoramento-ativo\/","url":"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/monitoramento-ativo\/","name":"Monitoramento Ativo: Acompanhamento Urol\u00f3gico | Rigicon","isPartOf":{"@id":"https:\/\/www.rigicon.com\/pt-br\/#website"},"datePublished":"2025-07-22T12:24:08+00:00","dateModified":"2026-10-06T16:50:55+00:00","description":"Saiba sobre monitoramento ativo na urologia: acompanhamento regular de condi\u00e7\u00f5es como angiomiolipoma, c\u00e1lculos renais e tumores de baixo risco. EAU.","breadcrumb":{"@id":"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/monitoramento-ativo\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rigicon.com\/pt-br\/glossary-term\/monitoramento-ativo\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/monitoramento-ativo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/www.rigicon.com\/pt-br\/"},{"@type":"ListItem","position":2,"name":"Glossary Terms","item":"https:\/\/www.rigicon.com\/pt-br\/urology-glossary\/"},{"@type":"ListItem","position":3,"name":"Monitoramento Ativo"}]},{"@type":"WebSite","@id":"https:\/\/www.rigicon.com\/pt-br\/#website","url":"https:\/\/www.rigicon.com\/pt-br\/","name":"Rigicon","description":"Innovative Urological Solutions","publisher":{"@id":"https:\/\/www.rigicon.com\/pt-br\/#organization"},"alternateName":"Innovative Urological Solutions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rigicon.com\/pt-br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/www.rigicon.com\/pt-br\/#organization","name":"Rigicon, Inc.","alternateName":"Innovative Urological Solutions","url":"https:\/\/www.rigicon.com\/pt-br\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.rigicon.com\/pt-br\/#\/schema\/logo\/image\/","url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/07\/cropped-Logo-Square-Kopya.jpg","contentUrl":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/07\/cropped-Logo-Square-Kopya.jpg","width":512,"height":512,"caption":"Rigicon, Inc."},"image":{"@id":"https:\/\/www.rigicon.com\/pt-br\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/rigiconurology\/","https:\/\/x.com\/rigiconurology","https:\/\/www.instagram.com\/rigiconurology\/","https:\/\/www.youtube.com\/@Rigicon\/podcasts","https:\/\/www.youtube.com\/Rigicon","https:\/\/www.threads.com\/@rigiconurology","https:\/\/www.linkedin.com\/company\/rigicon\/","https:\/\/www.wikidata.org\/wiki\/Q141595822"],"description":"A Rigicon \u00e9 uma fabricante especializada, sediada nos EUA, de dispositivos de urologia prot\u00e9tica: pr\u00f3teses penianas, esf\u00edncteres urin\u00e1rios artificiais e pr\u00f3teses testiculares, comercializados em mais de 75 pa\u00edses.","email":"operations@rigicon.com","telephone":"+1 (888) 202-9790","legalName":"Rigicon, Inc.","vatID":"81-3545645","taxID":"81-3545645","duns":"045247683"}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/glossary-term\/12732","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/glossary-term"}],"about":[{"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/types\/glossary-term"}],"wp:attachment":[{"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/media?parent=12732"}],"wp:term":[{"taxonomy":"glossary-category","embeddable":true,"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/glossary-category?post=12732"},{"taxonomy":"glossary-product","embeddable":true,"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/glossary-product?post=12732"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}